CARDIFF ONCOLOGY, INC. Interest Income, Operating
CARDIFF ONCOLOGY, INC. (CRDF) reported Interest Income, Operating of $926.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOperating · last filed 2024-05-02
- CARDIFF ONCOLOGY, INC. interest income, operating for the quarter ending 2024-03-31 was $926.00K, a 1.49% decline year-over-year.
- CARDIFF ONCOLOGY, INC. interest income, operating for the quarter ending 2023-09-30 was $1.07M, a 133.19% increase year-over-year.
- CARDIFF ONCOLOGY, INC. interest income, operating for the quarter ending 2023-06-30 was $1.05M, a 316.21% increase year-over-year.
- CARDIFF ONCOLOGY, INC. interest income, operating for the quarter ending 2023-03-31 was $940.00K, a 623.08% increase year-over-year.
| Period end | Interest Income, Operating 3 month | Interest Income, Operating 3 month as first filed | Interest Income, Operating 6 month | Interest Income, Operating 6 month as first filed | Interest Income, Operating 9 month | Interest Income, Operating 9 month as first filed |
|---|---|---|---|---|---|---|
| 2024-03-31 | $926.00K 10-Q · filed 2024-05-02 | |||||
| 2023-09-30 | $1.07M 10-Q · filed 2023-11-02 | $2.12M derived: sum of 2 quarters · filed 2023-11-02 | $3.06M 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $1.05M 10-Q · filed 2023-08-09 | $1.99M 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | $940.00K 10-Q · filed 2024-05-02 | |||||
| 2022-09-30 | $458.00K 10-Q · filed 2023-11-02 | $711.00K derived: sum of 2 quarters · filed 2023-11-02 | $841.00K 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | $253.00K 10-Q · filed 2023-08-09 | $383.00K 10-Q · filed 2023-08-09 | ||||
| 2022-03-31 | $130.00K 10-Q · filed 2023-05-04 | |||||
| 2021-09-30 | $70.00K 10-Q · filed 2022-11-03 | $141.00K derived: sum of 2 quarters · filed 2022-11-03 | $185.00K 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | $71.00K 10-Q · filed 2022-08-04 | $115.00K 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | $57.00K 10-Q · filed 2022-05-05 | |||||
| 2020-09-30 | $16.00K 10-Q · filed 2021-11-04 | $15.86K 10-Q · filed 2020-11-05 | $32.00K derived: sum of 2 quarters · filed 2021-11-04 | $67.00K 10-Q · filed 2021-11-04 | $67.36K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $16.00K 10-Q · filed 2021-08-05 | $15.67K 10-Q · filed 2020-08-11 | $51.00K 10-Q · filed 2021-08-05 | $51.49K 10-Q · filed 2020-08-11 | ||
| 2020-03-31 | $36.00K 10-Q · filed 2021-05-06 | $35.82K 10-Q · filed 2020-05-07 | ||||
| 2019-09-30 | $53.70K 10-Q · filed 2020-11-05 | $123.46K derived: sum of 2 quarters · filed 2020-11-05 | $188.20K 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $69.76K 10-Q · filed 2020-08-11 | $134.50K 10-Q · filed 2020-08-11 | ||||
| 2019-03-31 | $64.74K 10-Q · filed 2020-05-07 | |||||
| 2018-09-30 | $85.94K 10-Q · filed 2019-11-07 | $122.14K derived: sum of 2 quarters · filed 2019-11-07 | $143.91K 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | $36.20K 10-Q · filed 2019-08-08 | $57.97K 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | $21.77K 10-Q · filed 2019-05-07 | |||||
| 2017-09-30 | $20.65K 10-Q · filed 2018-11-07 | $132.51K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |